CA2689364A1 - Distributeur et procede d'obtention de materiau - Google Patents
Distributeur et procede d'obtention de materiau Download PDFInfo
- Publication number
- CA2689364A1 CA2689364A1 CA2689364A CA2689364A CA2689364A1 CA 2689364 A1 CA2689364 A1 CA 2689364A1 CA 2689364 A CA2689364 A CA 2689364A CA 2689364 A CA2689364 A CA 2689364A CA 2689364 A1 CA2689364 A1 CA 2689364A1
- Authority
- CA
- Canada
- Prior art keywords
- liquid
- outlet
- fibre
- polymer
- mat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 116
- 239000000463 material Substances 0.000 title claims description 85
- 239000007788 liquid Substances 0.000 claims description 218
- 239000000835 fiber Substances 0.000 claims description 87
- 229920000642 polymer Polymers 0.000 claims description 55
- 239000004480 active ingredient Substances 0.000 claims description 44
- 210000003491 skin Anatomy 0.000 claims description 42
- 239000002245 particle Substances 0.000 claims description 33
- 230000005684 electric field Effects 0.000 claims description 28
- 239000000758 substrate Substances 0.000 claims description 23
- 210000004027 cell Anatomy 0.000 claims description 19
- 239000012634 fragment Substances 0.000 claims description 17
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 16
- 108010049003 Fibrinogen Proteins 0.000 claims description 15
- 102000008946 Fibrinogen Human genes 0.000 claims description 15
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 15
- 108090000190 Thrombin Proteins 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 15
- 229940012952 fibrinogen Drugs 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 15
- 239000007921 spray Substances 0.000 claims description 15
- 238000000151 deposition Methods 0.000 claims description 14
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 13
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 13
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 13
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 13
- -1 antiseptics Substances 0.000 claims description 13
- 230000001276 controlling effect Effects 0.000 claims description 13
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 13
- 239000003102 growth factor Substances 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 230000008021 deposition Effects 0.000 claims description 9
- 210000004872 soft tissue Anatomy 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 9
- 230000017423 tissue regeneration Effects 0.000 claims description 9
- 102000004877 Insulin Human genes 0.000 claims description 8
- 108090001061 Insulin Proteins 0.000 claims description 8
- 230000012010 growth Effects 0.000 claims description 8
- 229940125396 insulin Drugs 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 108090000695 Cytokines Proteins 0.000 claims description 7
- 102000004127 Cytokines Human genes 0.000 claims description 7
- 102000009123 Fibrin Human genes 0.000 claims description 7
- 108010073385 Fibrin Proteins 0.000 claims description 7
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 7
- 229940088710 antibiotic agent Drugs 0.000 claims description 7
- 230000008472 epithelial growth Effects 0.000 claims description 7
- 229950003499 fibrin Drugs 0.000 claims description 7
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 7
- 239000004626 polylactic acid Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 108091005804 Peptidases Proteins 0.000 claims description 6
- 102000035195 Peptidases Human genes 0.000 claims description 6
- 229940035676 analgesics Drugs 0.000 claims description 6
- 239000000730 antalgic agent Substances 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 230000002141 anti-parasite Effects 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 229940121375 antifungal agent Drugs 0.000 claims description 6
- 239000003096 antiparasitic agent Substances 0.000 claims description 6
- 229940125687 antiparasitic agent Drugs 0.000 claims description 6
- 229940064004 antiseptic throat preparations Drugs 0.000 claims description 6
- 239000003018 immunosuppressive agent Substances 0.000 claims description 6
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 6
- 239000000021 stimulant Substances 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 229960005486 vaccine Drugs 0.000 claims description 6
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 239000003899 bactericide agent Substances 0.000 claims description 5
- 229920002988 biodegradable polymer Polymers 0.000 claims description 5
- 239000004621 biodegradable polymer Substances 0.000 claims description 5
- 210000002345 respiratory system Anatomy 0.000 claims description 5
- 210000004927 skin cell Anatomy 0.000 claims description 5
- 229940124549 vasodilator Drugs 0.000 claims description 5
- 239000003071 vasodilator agent Substances 0.000 claims description 5
- 229920000954 Polyglycolide Polymers 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000004633 polyglycolic acid Substances 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 230000002548 cytokinetic effect Effects 0.000 claims description 3
- 229940088598 enzyme Drugs 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 230000001413 cellular effect Effects 0.000 claims description 2
- 230000002452 interceptive effect Effects 0.000 claims description 2
- 230000005019 pattern of movement Effects 0.000 claims description 2
- 238000005086 pumping Methods 0.000 claims description 2
- 230000037390 scarring Effects 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 229960004072 thrombin Drugs 0.000 claims 13
- 230000002439 hemostatic effect Effects 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 239000002184 metal Substances 0.000 abstract description 2
- 239000004020 conductor Substances 0.000 abstract 1
- 239000003094 microcapsule Substances 0.000 description 34
- 206010052428 Wound Diseases 0.000 description 33
- 208000027418 Wounds and injury Diseases 0.000 description 32
- 239000000306 component Substances 0.000 description 23
- 238000000576 coating method Methods 0.000 description 22
- 239000007787 solid Substances 0.000 description 22
- 239000011248 coating agent Substances 0.000 description 21
- 241001465754 Metazoa Species 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000155 melt Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000011149 active material Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 238000007711 solidification Methods 0.000 description 4
- 230000008023 solidification Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 102400000368 Surface protein Human genes 0.000 description 3
- 238000006065 biodegradation reaction Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000007380 fibre production Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000005426 pharmaceutical component Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- JDSQBDGCMUXRBM-UHFFFAOYSA-N 2-[2-(2-butoxypropoxy)propoxy]propan-1-ol Chemical compound CCCCOC(C)COC(C)COC(C)CO JDSQBDGCMUXRBM-UHFFFAOYSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005520 electrodynamics Effects 0.000 description 1
- 238000007787 electrohydrodynamic spraying Methods 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 239000000677 immunologic agent Substances 0.000 description 1
- 229940124541 immunological agent Drugs 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Linear Motors (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615387.9A GB9615387D0 (en) | 1996-07-23 | 1996-07-23 | Dispensing device and process |
| GB9620064.7 | 1996-09-26 | ||
| GBGB9620064.7A GB9620064D0 (en) | 1996-07-23 | 1996-09-26 | Dispensing device and processes |
| GB9615387.9 | 1996-09-26 | ||
| CA2296334A CA2296334C (fr) | 1996-07-23 | 1997-07-22 | Distributeur et procede d'obtention de materiau |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2296334A Division CA2296334C (fr) | 1996-07-23 | 1997-07-22 | Distributeur et procede d'obtention de materiau |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2689364A1 true CA2689364A1 (fr) | 1998-01-29 |
Family
ID=10797315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2689364A Abandoned CA2689364A1 (fr) | 1996-07-23 | 1997-07-22 | Distributeur et procede d'obtention de materiau |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | ATE446809T1 (fr) |
| CA (1) | CA2689364A1 (fr) |
| DE (1) | DE69739640D1 (fr) |
| GB (2) | GB9615387D0 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013144806A2 (fr) | 2012-03-24 | 2013-10-03 | Michael Blum | Systèmes et procédés de préparation d'un mélange contrôlé en vue d'un traitement hyperthermal |
-
1996
- 1996-07-23 GB GBGB9615387.9A patent/GB9615387D0/en active Pending
- 1996-09-26 GB GBGB9620064.7A patent/GB9620064D0/en active Pending
-
1997
- 1997-07-22 DE DE69739640T patent/DE69739640D1/de not_active Expired - Lifetime
- 1997-07-22 CA CA2689364A patent/CA2689364A1/fr not_active Abandoned
- 1997-07-22 AT AT03077325T patent/ATE446809T1/de not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013144806A2 (fr) | 2012-03-24 | 2013-10-03 | Michael Blum | Systèmes et procédés de préparation d'un mélange contrôlé en vue d'un traitement hyperthermal |
| US9642981B2 (en) | 2012-03-24 | 2017-05-09 | Michael Blum | Systems and methods of preparing a controlled mixture for hyperthermal treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9620064D0 (en) | 1996-11-13 |
| GB9615387D0 (en) | 1996-09-04 |
| DE69739640D1 (de) | 2009-12-10 |
| ATE446809T1 (de) | 2009-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0912251B1 (fr) | Distributeur et procede d'obtention de materiau | |
| US7193124B2 (en) | Method for forming material | |
| US6252129B1 (en) | Dispensing device and method for forming material | |
| US7977527B2 (en) | Dispensing device and method for forming material | |
| US9050611B2 (en) | High mass throughput particle generation using multiple nozzle spraying | |
| KR100289783B1 (ko) | 분무장치 | |
| AU2001261625A1 (en) | High mass throughput particle generation using multiple nozzle spraying | |
| AU2009208883B2 (en) | Method for making patches by electrospray | |
| EP1140262B1 (fr) | Inhalateur | |
| JP2001513423A (ja) | 投与装置 | |
| EP1056497B1 (fr) | Appareil d'inhalation | |
| JPH09510654A (ja) | 分配装置 | |
| WO2016140570A1 (fr) | Micro-particules sur mesure | |
| US20050064168A1 (en) | Electric field spraying of surgically implantable components | |
| CA2689364A1 (fr) | Distributeur et procede d'obtention de materiau | |
| US20040135015A1 (en) | Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20130604 |
|
| FZDE | Discontinued |
Effective date: 20130604 |